| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.05 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.06 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |